A phase II trial of Novaferon for Locally Advanced Pancreatic Adenocarcinoma
Phase of Trial: Phase II
Latest Information Update: 20 Oct 2016
At a glance
- Drugs Novaferon (Primary)
- Indications Pancreatic cancer
- Focus Therapeutic Use
- 17 Oct 2016 Status changed from recruiting to suspended.
- 21 May 2012 Planned end date changed from 1 Apr 2011 to 31 Jul 2011 as reported by Chinese Clinical Trial Register.
- 17 Sep 2010 New trial record